Cited by 1,939Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

Heeringa, Jan, van der Kuip, Deirdre A.M., Hofman, Albert, Kors, Jan A., van Herpen, Gerard, Stricker, Bruno H.Ch., Stijnen, Theo, Lip, Gregory Y.H., Witteman, Jacqueline C.M.·2006·European Heart Journal

DOI 10.1093/eurheartj/ehi825

Open this paper in CoChat — free account

Abstract

AIMS: We aimed to investigate the prevalence and incidence of atrial fibrillation (AF) in a large European population-based study. METHODS AND RESULTS: The study is part of the Rotterdam study, a population-based prospective cohort study among subjects aged 55 years and above. The prevalence at baseline was assessed in 6808 participants. Incidence of AF was investigated during a mean follow-up period of 6.9 years in 6432 persons. We identified 376 prevalent and 437 incident cases. Overall prevalence was 5.5%, rising from 0.7% in the age group 55-59 years to 17.8% in those aged 85 years and above. The overall incidence rate was 9.9/1000 person-years. The incidence rate in the age group 55-59 years was 1.1/1000 person-years, rose to 20.7/1000 person-years in the age group 80-84 years and stabilized in those aged 85 years and above. Prevalence and incidence were higher in men than in women. The lifetime risk to develop AF at the age of 55 years was 23.8% in men and 22.2% in women. CONCLUSION: In this prospective study in a European population, the prevalence and incidence of AF increased with age and were higher in men than in women. The high lifetime risk to develop AF was similar to North American epidemiological data.

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehi825

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
Subcommittee, G. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,921
Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Epidemiologic Features of Chronic Atrial Fibrillation
Kannel, W. B., Abbott, R. D., Savage, D. D., & McNamara, P. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204293061703 · Cited by 2,304
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,282
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study
Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., Larson, M. G., Levy, D., Vasan, R. S., D’Agostino, R. B., Massaro, J. M., Beiser, A., Wolf, P. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000140263.20897.42 · Cited by 2,041
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01236-6 · Cited by 1,562
The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study
Krahn, A. D., Manfreda, J., TATE, R. B., Mathewson, F. A. L., & Cuddy, T. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80348-9 · Cited by 1,478

Show all 37 references

Sorted by citations

Items 201–300 of 999

Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke
Tada, H., Shiffman, D., Smith, J. G., Sjögren, M., Lubitz, S. A., Ellinor, P. T., Louie, J. Z., Catanese, J. J., Engström, G., Devlin, J. J., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.006072 · Cited by 110
Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Wilkinson, C., Mamas, M. A., Camm, A. J., & Gale, C. P. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100386 · Cited by 110
A review of the cost of atrial fibrillation
Wodchis, W. P., Bhatia, R. S., Leblanc, K., Meshkat, N., & Morra, D. (2012) · Value in Health · doi:10.1016/j.jval.2011.09.009 · Cited by 109
Evaluation and Initial Treatment of Supraventricular Tachycardia
Link, M. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1111259 · Cited by 109
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Meier, B., Blaauw, Y., Khattab, A. A., Lewalter, T., Sievert, H., Tondo, C., & Glikson, M. (2015) · EuroIntervention · doi:10.4244/eijy14m09_18 · Cited by 110
Reasons for Undertreatment with Oral Anticoagulants in Frail Geriatric Outpatients with Atrial Fibrillation
Tulner, L. R., van Campen, J. P. C. M., Kuper, I. M. J. A., Gijsen, G. J. P. T., Koks, C. H. W., Gillavry, M. R. M., van Tinteren, H., Beijnen, J. H., & Brandjes, D. P. M. (2009) · Drugs & Aging · doi:10.2165/11319540-000000000-00000 · Cited by 108
N‐3 Polyunsaturated Fatty Acids to Prevent Atrial Fibrillation: Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Mariani, J. A., Doval, H. C., Nul, D. R., Varini, S. D., Grancelli, H., Ferrante, D., Tognoni, G., & Macchia, A. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.005033 · Cited by 111
China suboptimal health cohort study: rationale, design and baseline characteristics
Wang, Y., Ge, S., Yan, Y., Wang, A., Zhao, Z., Yu, X., Qiu, J., Alzain, M. A., Wang, H., Fang, H., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1046-y · Cited by 106
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Slot, K. B., & Berge, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008980.pub2 · Cited by 109
Cardiac imaging for assessment of left atrial appendage stasis and thrombosis
Romero, J. E., Cao, J. J., Garcia, M. J., & Taub, C. C. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.77 · Cited by 105
Estimating the current and future prevalence of atrial fibrillation in the Australian adult population
Ball, J., Thompson, D. R., Ski, C. F., Carrington, M. J., Gerber, T., & Stewart, S. (2015) · The Medical Journal of Australia · doi:10.5694/mja14.00238 · Cited by 107
Racial/Ethnic Differences in the Prevalence of Atrial Fibrillation Among Older Adults—A Cross-Sectional Study
Shen, A. Y., Contreras, R., Sobnosky, S., Shah, A., Ichiuji, A., Jorgensen, M. B., Brar, S. S., & Chen, W. (2010) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30709-4 · Cited by 103
Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation
Hendriks, J., Tomini, F., van Asselt, T., Crijns, H., & Vrijhoef, H. (2013) · Europace · doi:10.1093/europace/eut055 · Cited by 100
Normal Thyroid Function and the Risk of Atrial Fibrillation: the Rotterdam Study
Chaker, L., Heeringa, J., Dehghan, A., Medici, M., Visser, W. E., Baumgartner, C., Albert Hofman, D., Rodondi, N., Peeters, R. P., & Franco, O. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2480 · Cited by 100
Self-citation
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 106
Self-citation
Update on atrial fibrillation: Part II
Savelieva, I., & Camm, A. J. (2008) · Clinical Cardiology · doi:10.1002/clc.20136 · Cited by 99
Accelerometer-derived physical activity and risk of atrial fibrillation
Khurshid, S. S., Weng, L.-C. C., Al‐Alusi, M. A., Halford, J. L., Haimovich, J. S., Benjamin, E. J., Trinquart, L., Ellinor, P. T., McManus, D. D., & Lubitz, S. A. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab250 · Cited by 98
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
Nielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
Self-citation
Sex Differences in Atrial Fibrillation
Andrade, J. G., Deyell, M. W., Lee, A. K. Y., & Macle, L. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.11.022 · Cited by 100
Meta-Analysis of Direct-Acting Oral Anticoagulants Compared With Warfarin in Patients >75 Years of Age
Malik, A. H., Yandrapalli, S., Aronow, W. S., Panza, J. A., & Cooper, H. A. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.02.060 · Cited by 102
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
Boriani, G., Vitolo, M., Diemberger, I., Proietti, M., Valenti, A. C., Malavasi, V. L., & Lip, G. Y. H. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab147 · Cited by 105
Self-citation
Update on Atrial Fibrillation: Part I
Savelieva, I., & Camm, A. J. (2008) · Clinical Cardiology · doi:10.1002/clc.20138 · Cited by 97
Thyroid Function and Sudden Cardiac Death: A Prospective Population-Based Cohort Study
Chaker, L., van den Berg, M. E., Niemeijer, M. N., Franco, O. H., Dehghan, A., Hofman, A., Rijnbeek, P. R., Deckers, J. W., Eijgelsheim, M., Stricker, B. H. C., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020789 · Cited by 97
Self-citation
Atrial fibrillation and bisphosphonate therapy
Pazianas, M., Compston, J. E., & Huang, C. L.-H. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091201 · Cited by 94
Stacking segment-based CNN with SVM for recognition of atrial fibrillation from single-lead ECG recordings
Nguyen, Q. H., Nguyen, B. P., Nguyen, T. B., Do, T. T. T., Mbinta, J. F., & Simpson, C. R. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.102672 · Cited by 98
Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins
Pinho-Gomes, A. C., Reilly, S., Brandes, R. P., & Casadei, B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5542 · Cited by 94
Mechanism of atrial functional mitral regurgitation in patients with atrial fibrillation: A study using three-dimensional transesophageal echocardiography
Ito, K., Abe, Y., Takahashi, Y., Shimada, Y., Fukumoto, H., Matsumura, Y., Naruko, T., Shibata, T., Yoshiyama, M., & Yoshikawa, J. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.03.013 · Cited by 94
Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management
Gumprecht, J. J., Domek, M., Lip, G. Y. H., & Shantsila, A. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0279-7 · Cited by 98
Self-citation
A Survey of Visual Analytics for Public Health
Preim, B., & Lawonn, K. (2019) · Computer Graphics Forum · doi:10.1111/cgf.13891 · Cited by 96
Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
Lip, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04302.x · Cited by 91
Self-citation
Detection of atrial fibrillation using contactless facial video monitoring
Couderc, J., Kyal, S., Mestha, L. K., Xu, B., Peterson, D. R., Xia, X., & HALL, B. W. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.08.035 · Cited by 92
Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice
Romanelli, R. J., Nolting, L., Dolginsky, M., Kym, E., & Orrico, K. B. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002369 · Cited by 92
Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance
Savelieva, I., Kourliouros, A., & Camm, A. J. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0468-y · Cited by 92
Statins and polyunsaturated fatty acids for treatment of atrial fibrillation
Savelieva, I., & Camm, A. J. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1038 · Cited by 92
Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes
Dzeshka, M. S., Shahid, F., Shantsila, A., & Lip, G. Y. H. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx013 · Cited by 91
Self-citation
Rhythm Control in Heart Failure Patients With Atrial Fibrillation
Trulock, K. M., Narayan, S. M., & Piccini, J. P. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1169 · Cited by 92
Atrial fibrillation—the growing epidemic
Lip, G. Y. H., Kakar, P., & Watson, T. (2007) · Heart · doi:10.1136/hrt.2006.110791 · Cited by 90
Self-citation
Atrial Fibrillation and Atrial Flutter in Human Immunodeficiency Virus-Infected Persons
Hsu, J. C., Li, Y., Marcus, G. M., Hsue, P. Y., Scherzer, R., Grünfeld, C., & Shlipak, M. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.022 · Cited by 90
Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015
Kjerpeseth, L. J., Ellekjær, H., Selmer, R. M., Ariansen, I., Furu, K., & Skovlund, E. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2296-1 · Cited by 92
Diagnostic Accuracy of Smartwatches for the Detection of Cardiac Arrhythmia: Systematic Review and Meta-analysis
Nazarian, S., Lam, K., Darzi, A. W., & Ashrafian, H. (2021) · Journal of Medical Internet Research · doi:10.2196/28974 · Cited by 101
Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data
Charlemagne, A., Blacher, J., Cohen, A. A., Collet, J., Diévart, F., de Groote, P., Hanon, O., Leenhardt, A., Pinel, J., Pisica–Donose, G., et al. (2011) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2010.11.012 · Cited by 87
The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systemsThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Boriani, G., Diemberger, I., Martignani, C., Biffi, M., & Branzi, A. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi651 · Cited by 90
Atrial fibrillation in highly trained endurance athletes — Description of a syndrome
Sanchis-Gomar, F., Perez-Quilis, C., Lippi, G., Cervellin, G., Leischik, R., Löllgen, H., Serrano-Ostáriz, E., & Lucia, A. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.047 · Cited by 95
Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials
Deitelzweig, S., Amin, A., Jing, Y., Makenbaeva, D., Wiederkehr, D., Lin, J., & Graham, J. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.680555 · Cited by 91
Effects of dabigatran according to age in atrial fibrillation
Lauw, M. N., Eikelboom, J. W., Coppens, M., Wallentin, L. C., Yusuf, S., Ezekowitz, M. D., Oldgren, J., Nakamya, J., Wang, J., & Connolly, S. J. (2017) · Heart · doi:10.1136/heartjnl-2016-310358 · Cited by 88
World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update
Freedman, B., Hindricks, G., Banerjee, A., Baranchuk, A. M., Ching, C. K., Du, X., Fitzsimons, D., Healey, J. S., Ikeda, T., Lobban, T., et al. (2021) · Global Heart · doi:10.5334/gh.1023 · Cited by 95
Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure
Souza, A. I. D., Cardin, S., Wait, R., Chung, Y., Vijayakumar, M., Maguy, A., Camm, A. J., & Nattel, S. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.07.008 · Cited by 89
Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case–control study
Erichsen, R., Christiansen, C. F., Mehnert, F., Weiss, N. S., Baron, J. A., & Sørensen, H. T. (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0701-9 · Cited by 88
Atrial fibrillation: review of current treatment strategies
Xu, J., Luc, J. G. Y., & Phan, K. H. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.09.13 · Cited by 88
Association Between Atrial Fibrillation and Sudden Cardiac Death
Waldmann, V., Jouven, X., Narayanan, K., Piot, O., Chugh, S. S., Albert, C. M., & Marijon, É. (2020) · Circulation Research · doi:10.1161/circresaha.120.316756 · Cited by 91
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Lafuente‐Lafuente, C., Longás-Tejero, M. A., Bergmann, J., & Belmin, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005049.pub3 · Cited by 90
Differences in Epidemiology and Risk Factors for Atrial Fibrillation Between Women and Men
Kavousi, M. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00003 · Cited by 96
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
Schuermans, A., Vlasschaert, C., Nauffal, V., Cho, S. M. J., Uddin, M. M., Nakao, T., Niroula, A., Klarqvist, M. D. R., Weeks, L. D., Lin, A. E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad670 · Cited by 93
Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial Fibrillation
Sharma, R., Oni, O. A., Gupta, K., Sharma, M., Sharma, R., Singh, V., Parashara, D., Surineni, K., Dawn, B., Chen, G., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004880 · Cited by 86
The Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort Data
Lee, H., Kim, T., Baek, Y., Uhm, J., Pak, H., Lee, M., & Joung, B. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.0045 · Cited by 85
Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
Grymonprez, M., Steurbaut, S., de Backer, T. L., Petrović, M., & Lahousse, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.583311 · Cited by 84
Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial
Uittenbogaart, S. B., Gurp, N. V.-V., Lucassen, W. A. M., Winkens, B., Nielen, M. M. J., Erkens, P. M. G., Knottnerus, J. A., van Weert, H. C. P. M., & Stoffers, J. (2020) · BMJ · doi:10.1136/bmj.m3208 · Cited by 85
A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · CHEST Journal · doi:10.1378/chest.13-2103 · Cited by 87
Self-citation
Sequential Hybrid Procedure for Persistent Atrial Fibrillation
Bulava, A., Mokráček, A., Haniš, J., Kurfirst, V., Eisenberger, M., & Pešl, L. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001754 · Cited by 84
Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data
Johansson, L., Norberg, J., Jansson, J., & Bäckström, S. (2013) · Clinical Epidemiology · doi:10.2147/clep.s53420 · Cited by 84
Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines
Savelieva, I., Graydon, R., & Camm, A. J. (2013) · EP Europace · doi:10.1093/europace/eut274 · Cited by 85
Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm
Smorodinova, N., Bláha, M., Melenovský, V., Rozsívalová, K., Přidal, J., Ďurišová, M., Pirk, J., Kautzner, J., & Kučera, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172691 · Cited by 83
Cohort design and natural language processing to reduce bias in electronic health records research
Khurshid, S. S., Reeder, C., Harrington, L. X., Singh, P., Sarma, G., Friedman, S. F., Achille, P. D., Diamant, N., Cunningham, J. W., Turner, A. C., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00590-0 · Cited by 82
Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
Savelieva, I., & Camm, A. J. (2013) · Clinical Cardiology · doi:10.1002/clc.22204 · Cited by 84
Atrial Fibrillation and Risk of Cancer: A Danish Population‐Based Cohort Study
Vinter, N., Christesen, A. M. S., Fenger‐Grøn, M., Tjønneland, A. M., & Frost, L. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009543 · Cited by 82
Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation
Willems, S., Meyer, C. G., de Bono, J. P., Brandes, A., Eckardt, L., Elvan, A., Gelder, I. C. V., Goette, A., Gulizia, M. M., Haegeli, L., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz782 · Cited by 80
Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey
Wang, X., Fu, Q., Song, F., Li, W., Yin, X., Yue, W., Yan, F., Zhang, H., Zhang, H., Teng, Z., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.131 · Cited by 79
Chronic obstructive pulmonary disease and the development of atrial fibrillation
Grymonprez, M., Vakaet, V., Kavousi, M., Stricker, B. H. C., Ikram, M. A., Heeringa, J., Franco, O. H., Brusselle, G., & Lahousse, L. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.09.056 · Cited by 80
Self-citation
Time Course of Atrial Fibrillation in Patients With Congenital Heart Defects
Teuwen, C. P., Ramdjan, T. T. T. K., Götte, M., Brundel, B. J. J. M., Evertz, R., Vriend, J. W. J., Molhoek, S. G., Dorman, H. G. R., van Opstal, J. M., Konings, T. C., et al. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003272 · Cited by 79
Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review
Sankaranarayanan, R., Kirkwood, G. J., Dibb, K. M., & Garratt, C. J. (2013) · Cardiology Research and Practice · doi:10.1155/2013/976976 · Cited by 82
Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients
Lip, G. Y. H., & Lane, D. A. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0106 · Cited by 78
Self-citation
Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry
Ruff, C. T., Bhatt, D. L., Steg, P. G., Gersh, B. J., Alberts, M. J., Hoffman, E. B., Ohman, E. M., Eagle, K. A., Lip, G. Y. H., & Goto, S. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.030 · Cited by 74
Self-citation
Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial
Diederichsen, S. Z., Haugan, K., Køber, L., Højberg, S., Brandes, A., Kronborg, C., Graff, C., Holst, A. G., Nielsen, J. B., Krieger, D. W., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.02.017 · Cited by 74
Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people
Hanon, O., Assayag, P., Belmin, J., Collet, J., Émeriau, J. P., Fauchier, L., Forette, F., Friocourt, P., Gentric, A., Leclercq, C., et al. (2013) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2013.04.001 · Cited by 72
Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium
Morseth, B., Geelhoed, B., Linneberg, A. R., Johansson, L., Kuulasmaa, K., Salomaa, V. V., Iacoviello, L., Costanzo, S., Söderberg, S., Niiranen, T., et al. (2021) · Open Heart · doi:10.1136/openhrt-2021-001624 · Cited by 77
Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer
Abonowara, A., Quraishi, A. U. R., Sapp, J. L., Alqambar, M. H., Saric, A., O’Connell, C. M., Rajaraman, M. M., Hart, R. D., & Imran, S. A. (2012) · Clinical and investigative medicine · doi:10.25011/cim.v35i3.16591 · Cited by 73
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients
Silverio, A., Maio, M. D., Prota, C., Angelis, E. D., Radano, I., Citro, R., Carrizzo, A., Ciccarelli, M., Vecchione, C., Capodanno, D., et al. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz073 · Cited by 73
Long-Term Prognostic Value of P-Wave Characteristics for the Development of Atrial Fibrillation in Subjects Aged 55 to 74 Years at Baseline
Bacquer, D. D., Willekens, J., & Backer, G. D. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.017 · Cited by 73
Gender differences in patients referred for atrial fibrillation management to a tertiary center
ROTEN, L., RIMOLDI, S. F., SCHWICK, N., SAKATA, T., HEIMGARTNER, C., FUHRER, J., DELACRÉTAZ, E., & TANNER, H. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02335.x · Cited by 73
Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation
Shields, A. M., & Lip, G. Y. H. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12360 · Cited by 72
Self-citation
Detection of Paroxysmal Atrial Fibrillation in Acute Stroke Patients
Rizos, T., Rasch, C., Jenetzky, E., Hametner, C., Kathoefer, S., Reinhardt, R., Hepp, T., Hacke, W., & Veltkamp, R. C. (2010) · Cerebrovascular Diseases · doi:10.1159/000316885 · Cited by 70
Global Survey of the Frequency of Atrial Fibrillation–Associated Stroke
Perera, K. S., Vanassche, T., Bosch, J., Swaminathan, B., Mundl, H., Giruparajah, M., Barboza, M. A., O'Donnell, M. J., Schneider, M. G., Hankey, G. J., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.013378 · Cited by 70
Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector
Ni, L., Scott, L., Campbell, H. M., Pan, X., Alsina, K. M., Reynolds, J. O., Philippen, L. E., Hulsurkar, M. M., Lagor, W. R., Li, N., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313811 · Cited by 69
Evaluation of the Incidence of New-Onset Atrial Fibrillation After Aortic Valve Replacement
Kalra, R., Patel, N., Doshi, R. P., Arora, G., & Arora, P. K. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0205 · Cited by 69
Hybrid Procedure (Endo/Epicardial) versus Standard Manual Ablation in Patients Undergoing Ablation of Longstanding Persistent Atrial Fibrillation: Results from a Single Center
Edgerton, Z. J., Perini, A. P., Horton, R., Trivedi, C. G., Santangeli, P., Bai, R., Gianni, C., Mohanty, S., Burkhardt, J. D., Gallinghouse, G. J., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12926 · Cited by 70
Atrial Fibrillation and Declining Physical Performance in Older Adults
Magnani, J. W., Wang, N., Benjamin, E. J., Garcia, M. E., Bauer, D. C., Butler, J., Ellinor, P. T., Kritchevsky, S. B., Marcus, G. M., Newman, A. B., et al. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003525 · Cited by 70
Recurrent Atrial Fibrillation After Initial Long-Term Ablation Success
Shah, S. Y., Barakat, A. F., Saliba, W. I., Rehman, K. A., Tarakji, K. G., Rickard, J., Bassiouny, M., Baranowski, B. J., TCHOU, P. J., Bhargava, M., et al. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005785 · Cited by 70
Prevalence and Incidence of Atrial Fibrillation Among Older Primary Care Patients
Khurshid, S. S., Ashburner, J. M., Ellinor, P. T., McManus, D. D., Atlas, S. J., Singer, D. E., & Lubitz, S. A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.55838 · Cited by 69
Management of Atrial Fibrillation in Critically Ill Patients
Arrigo, M., Béttex, D., & Rudiger, A. (2014) · Critical Care Research and Practice · doi:10.1155/2014/840615 · Cited by 71
Systematic Review and Meta-analysis of the Efficacy of Cardioversion by Vernakalant and Comparators in Patients with Atrial Fibrillation
Bash, L. D., Buono, J. L., Davies, G., Martin, A., Fahrbach, K. R., Phatak, H. M., Avetisyan, R., & Mwamburi, M. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6374-4 · Cited by 66
Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial
Glover, B. M., Walsh, S. J., McCann, C. J., Moore, M. J., Manoharan, G., Dalzell, G. W. N., McAllister, A. S., McClements, B. M., MCENEANEY, D. J., Trouton, T. G., et al. (2007) · Heart · doi:10.1136/hrt.2007.120782 · Cited by 67
Prevalence and Incidence of Atrial Fibrillation and Other Arrhythmias in the General Older Population: Findings From the Swedish National Study on Aging and Care
Lindberg, T., Wimo, A. B., Elmståhl, S., Qiu, C., Bohman, D., & Berglund, J. S. (2019) · Gerontology and Geriatric Medicine · doi:10.1177/2333721419859687 · Cited by 67
Asymptomatic Polyvascular Abnormalities in Community (APAC) Study in China: Objectives, Design and Baseline Characteristics
Zhou, Y., Li, Y., Xu, L., Xu, J., Wang, A., Gao, X., Wu, S., Wei, W. B., Zhao, X., & Jonas, J. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084685 · Cited by 66
Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry
Šubic, A., Čermáková, P., Religa, D., Han, S., von Euler, M., Kåreholt, I., Johnell, K., Fastbom, J., Bognandi, L., Winblad, B. G., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170575 · Cited by 68
Epidemiology of Atrial Fibrillation and Heart Failure
Karnik, A. A., Gopal, D. M., Ko, D., Benjamin, E. J., & Helm, R. H. (2019) · Cardiology Clinics · doi:10.1016/j.ccl.2019.01.001 · Cited by 66
Exosomal miR-320d derived from adipose tissue-derived MSCs inhibits apoptosis in cardiomyocytes with atrial fibrillation (AF)
Liu, L., Zhang, H., Mao, H., Li, X., & Hu, Y. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1671432 · Cited by 66
Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013
Martínez, C., Katholing, A., Wallenhorst, C., Granziera, S., Cohen, A. T., & Freedman, S. B. (2015) · Heart · doi:10.1136/heartjnl-2015-307808 · Cited by 65
Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients With Atrial Fibrillation
Slot, K. B., & Berge, E. (2013) · Stroke · doi:10.1161/strokeaha.113.003453 · Cited by 65
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort
Huisman, M. V., Sheng, C., Diener, H., Dubner, S., Halperin, J. L., Rothman, K. J., Teutsch, C., Schoof, N., Kleine, E., Bartels, D. B., et al. (2016) · EP Europace · doi:10.1093/europace/euw073 · Cited by 66
Self-citation
Atrial Fibrillation Following Patent Foramen Ovale Closure
Chen, J. Z.-J., & Thijs, V. (2021) · Stroke · doi:10.1161/strokeaha.120.030293 · Cited by 66

Authors: Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., Stijnen, T., Lip, G. Y. H., & Witteman, J. C. M.
Affiliations: Erasmus MC (NL)
Birmingham City Hospital (GB)
Corresponding author: Heeringa, Jan
ORCID: Kors, Jan A.
Stricker, Bruno H.Ch.
Stijnen, Theo
Lip, Gregory Y.H.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2006-03-09
Volume: 27
Issue: 8
Pages: 949-953
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/ehi825
OpenAlex: W2148056560
Cited by: 1,939
References: 37
Citations by year: 2026: 38 · 2025: 58 · 2024: 87 · 2023: 89 · 2022: 105 · 2021: 109 · 2020: 142 · 2019: 122 · 2018: 123 · 2017: 146 · 2016: 112 · 2015: 153 · 2014: 118 · 2013: 141 · 2012: 113
FWCI: 31.18
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Digest of the World Core Medical Journals(Cardiology)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: atrial fibrillation, prevalence, incidence, lifetime risk, age differences, sex differences, older adults, Rotterdam Study
MeSH terms: Aged, Aged, 80 and over, Atrial Fibrillation, Epidemiologic Methods, Female, Humans, Male, Middle Aged, Netherlands, Age Distribution, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks